IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate
The move follows recent FDA approvals of anti-amyloid drugs from Eli Lilly and Eisai/Biogen.
The post IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate appeared first on Green Market Report.
